We cordially invite you to participate in the "4th International Conference on Oncology" taking place in Dubai, UAE, on May 19-20, 2025. Centered around the theme, "Global Oncology: Addressing Cancer Worldwide" this conference will bring together esteemed oncologists, leading researchers, healthcare professionals, and industry leaders from around the world. Attendees will experience a rich agenda that includes keynote presentations, interactive workshops, engaging panel discussions, and poster sessions, encompassing a broad range of oncological topics. The event will spotlight the latest advancements in precision medicine, immunotherapy, emerging technologies, and novel treatment approaches, providing a premier platform for exchanging knowledge and fostering innovation in oncology research and clinical practice.

Oncology:
A high-level overview of emerging trends, technologies, and challenges in the field of oncology. From emerging therapies to personalized medicine, this session covers the latest advancements shaping the future of oncology.

Tumor Biology:
We'll explore the dynamic interactions between tumor cells and their microenvironment, uncovering key insights into genetic and epigenetic alterations driving tumorigenesis. Additionally, we'll discuss the metabolic adaptations of cancer cells and their impact on tumor growth and survival.

Cancer Diseases and Progression:
We'll delve into the intricate mechanisms driving tumor development, proliferation, and metastasis, shedding light on the dynamic interplay between cancer cells and their surrounding microenvironment. Through insightful discussions, we'll explore the diverse pathways and genetic alterations underpinning different cancer types, offering valuable insights into disease progression and therapeutic resistance.

Treatment Modalities:
From traditional approaches like surgery and chemotherapy to cutting-edge innovations such as immunotherapy and targeted therapy, we'll delve into the nuances of each modality and discuss their respective strengths and limitations. Through engaging discussions, we'll highlight the importance of personalized treatment plans tailored to each patient's unique characteristics and tumor biology.

Geriatric Oncology Challenges:
We’ll address the complexities of cancer care in older adults. We'll explore the unique considerations and obstacles faced in diagnosing, treating, and managing cancer in elderly patients, including issues related to comorbidities, functional status, and treatment tolerability.

Cancer Stem Cell Biology:
We'll unravel the enigmatic role of cancer stem cells in tumor heterogeneity, recurrence, and metastasis, shedding light on their unique properties and therapeutic implications. Through engaging discussions, we'll explore the dynamic interplay between cancer stem cells and the tumor microenvironment, uncovering novel strategies to target these elusive cells and disrupt tumor growth.

Pharmacology and Cancer Medicine:
From elucidating the molecular mechanisms of anticancer agents to exploring novel drug targets and treatment modalities, our discussions will encompass a diverse array of research endeavors. We'll also examine the translation of preclinical discoveries into clinical practice, evaluating the efficacy and safety of emerging therapies through rigorous clinical trials.

Diagnostic Techniques and Imaging:
We'll delve into the latest advancements in imaging modalities, such as MRI, CT, PET, and molecular imaging, and discuss their applications in early cancer detection, accurate staging, and treatment monitoring. Furthermore, we'll examine the development of novel biomarkers and imaging probes that offer insights into tumor biology and facilitate personalized treatment strategies.

Genetic Testing and Precision Medicine:
This session will illuminate the transformative potential of genomic technologies in shaping the future of cancer diagnosis and treatment. From elucidating the role of genetic mutations in cancer development to exploring personalized treatment strategies tailored to individual patients, our discussions will encompass cutting-edge research and innovative approaches.

Cancer Prevention and Risk Factors:
Our esteemed speakers will delve into topics such as lifestyle modifications, vaccination initiatives, and environmental risk reduction measures aimed at lowering the incidence of cancer. Through engaging presentations and interactive discussions, attendees will have the opportunity to gain valuable knowledge, exchange ideas, and explore innovative approaches to cancer prevention.

Patient Education and Advocacy:
This session will highlight the critical role of patient empowerment and advocacy in cancer care. Through informative presentations and interactive discussions, attendees will gain insights into the importance of educating patients about their diagnosis, treatment options, and supportive care resources. Additionally, we will explore the pivotal role of advocacy organizations and support networks in championing the needs of cancer patients and survivors.

Clinical Trials and Research:
This session will provide a comprehensive exploration of the latest advancements and breakthroughs in cancer research methodologies and clinical trial practices. Attendees will have the opportunity to engage with leading experts in the field, learn about innovative studies and therapeutic approaches, and discuss the implications of research findings on clinical practice.

Survivorship and Rehabilitation:
We welcome submissions focusing on various aspects of survivorship, including long-term effects of cancer treatment, psychosocial support, survivorship care planning, and strategies for enhancing quality of life post-treatment. Additionally, we encourage abstracts addressing rehabilitation interventions aimed at improving physical, emotional, and cognitive function in cancer survivors.

Nanotechnology in Cancer Treatment:
We welcome abstracts covering a wide range of topics, including nanoparticle-based drug delivery systems, nano-scale imaging technologies, and nanomaterials for targeted therapy and immunotherapy.

Public Health and Policy:
We welcome abstracts covering a wide range of topics, including tobacco control, cancer screening programs, healthcare policies, health disparities, and implementation science. Join us in exploring the intersection of public health and policy in the fight against cancer and shaping the future of cancer care. Submit your abstracts today and contribute to advancing knowledge, fostering collaboration, and driving positive change in cancer prevention and control.

Case Studies and Clinical Research:
This session will provide a unique opportunity for clinicians, researchers, and healthcare professionals to share their impactful case studies and innovative clinical research findings in the field of oncology. We welcome abstracts covering a broad spectrum of topics, including challenging patient cases, novel treatment approaches, therapeutic outcomes, and lessons learned from clinical practice.

Advantages of Participating at our Conference:

• Access to cutting-edge research, advancements, and best practices in Oncology.
• Establish valuable connections with peers, experts, and thought leaders in Oncology.
• Enhance clinical skills and stay abreast of the latest developments in the field.
• Exposure to innovative technologies, therapies, and approaches in cancer care.
• Stay informed about and contribute to discussions on cancer healthcare policies and initiatives.
• Learn from renowned speakers and experts through keynote sessions, workshops, and panel discussions.
• Best Poster Award nominations.
• Award for Outstanding Young Researcher.
• Gain insights into diverse global perspectives on oncology healthcare challenges and solutions.

Benefits of Participation for Delegate:

• Access to a diverse range of sessions, workshops, and presentations, providing comprehensive education on oncology and cancer care.
• Opportunities to connect with healthcare professionals, researchers, and experts in oncology, fostering potential collaborations and knowledge exchange.
• Stay updated on the latest research findings, advancements, and best practices in the field of cancer healthcare.
• Explore innovative products, technologies, and services in the oncology healthcare industry through access to the exhibition area.
• Engage in discussions, ask questions, and participate in interactive sessions, creating a dynamic and engaging learning environment.
• Obtain certificates of attendance or participation, recognizing the delegate's commitment to continuous learning and professional development.

Benefit of Participation for Sponsor:

• Gain significant visibility and exposure to a targeted audience in the Oncology sector.
• Position the sponsoring company as a thought leader by aligning with a reputable event in the oncology field.
• Opportunity to showcase products, services, and innovations to a relevant and engaged audience.
• Gain insights into market trends, needs, and preferences through direct interactions with conference attendees.
• Enhance brand credibility and trust within the cancer healthcare community by supporting a reputable congress.
• Demonstrate commitment to CSR by supporting an event focused on advancing healthcare for the elderly.

Patient assistance programs (PAPs), government cancer awareness campaigns, and the rising incidence of cancer globally, significant R&D efforts from major companies, and the growing need for individualized treatment are the main factors propelling the market's expansion. The need for and implementation of personalized medicine is fuelled by technical improvements that improve planning; as a result, the market is anticipated to increase. The use of artificial intelligence in customized care medicine enhances the ability of medical practitioners to design therapies and do early multi-cancer diagnostics. The demand for personalized medicine is increased by its usage in applications like the creation of tailored medical goods that use patient data to enhance the efficacy and safety of cancer patients' therapy.

Targeted therapy refers to medications that act by specifically targeting genes or proteins in cancer cells. In the rapidly developing field of targeted therapy in cancer research, scientists are examining a broad variety of novel targets. Additionally, the demand for targeted therapy to treat cancers like lymphoma is increased by the rising number of cases of cancer, which this therapy efficiently targets. It affects tumors; hence, market expansion is expected. For example, the American Cancer Society estimates that in 2025 there will be around 89,100 new cases of lymphoma diagnosed in the United States. As a result, the increased incidence of cancer cases stimulates demand for focused treatment and propels industry expansion.

Societies associated with ICO-2025

• Union for International Cancer Control (UICC)
• International Agency for Research on Cancer (IARC)
• European Society for Medical Oncology (ESMO)
• International Association for the Study of Lung Cancer (IASLC)
• International Gynecologic Cancer Society (IGCS)
• Multinational Association of Supportive Care in Cancer (MASCC)
• American Association for Cancer Research (AACR)
• Asia-Pacific Journal of Clinical Oncology (APJCO)
• Japanese Society of Medical Oncology (JSMO)
• Indian Society of Oncology (ISO)
• African Organization for Research and Training in Cancer (AORTIC)
• Australian and New Zealand Society of Palliative Medicine (ANZSPM)
• Middle East Cancer Consortium (MECC)

Top universities:

• Sidney Kimmel Comprehensive Cancer Center
• Helen Diller Family Comprehensive Cancer Center
• University of Texas MD Anderson Cancer Center
• Jonsson Comprehensive Cancer Center
• Yale Cancer Center
• Karolinska Comprehensive Cancer Center
• Cancer Science Institute of Singapore
• Severance Hospital Cancer Center
• NTU Cancer Center
• Peter MacCallum Cancer Centre
• Harry Perkins Institute of Medical Research
• Montreal Cancer Institute

Young Scientist Awards at ICO-2025 for the best research in the field of Oncology and Cancer research:
The Young Scientist Awards will be presented by MeetingsInt at the 4^th International Conference on Oncology, which will take place in Dubai, UAE, May 19–20, 2025. The newest developments and usage of cancer treatments are the main topics of this oncology conference. ICO-2025 and subsequent conferences will award excellent Young Scientist Awards to participants who have made a substantial contribution to the oncology scientific community. Through the Young Scientist Award, young researchers will have the chance to meet specialists and exchange experiences at our international conferences, offering them a strong opportunity for professional development.
Cancer immunology, cancer treatments and therapies, precision oncology, oncology biomarkers, cancer biology, and tumor microenvironment will be the primary areas of attention for oncology in 2025. The operating committee offers a venue for trainees, post-graduate/master's students, PhD candidates, and aspiring young researchers and investigators to present their work.

Eligibility:
Faculty members, Ph.D. candidates, post-doctoral fellows, young scientists, and intelligent final-year MSc and M.Phil. candidates. Scientific industry personnel are also eligible to take part.

Criteria:
The Young Scientist Feature provides a forum for young researchers to showcase their accomplishments and future directions, thereby advancing their careers in their fields.

• Acknowledgment as YRF Awardee Promotion on the conference website, Young Researcher Awards, and certificates
• Link on the conference website
• Recognition on Meetings Int. Award Page
• Chances to coordinate with partners around the world
• Research work can be published in the relevant journal without any publication fee.

Benefits:

• All presented abstracts will automatically be considered for the Award.
• All the presentations will be evaluated in the conference venue
• All the awards will be selected by the judges of the award category
• The winners of the Young Scientist Award will receive an award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

• All submissions must be in English.
• The topic must fit into the scientific sessions of the conference
• Each individual participant is allowed to submit maximum 2 papers
• The abstract must be submitted online as per the given abstract template
• Abstracts must be written in Times New Roman and the font size will be 12
• The abstract must contain the title, name, affiliation, country, speaker biography, recent photograph, image, and reference.

Acceptance:
In order to be eligible for the award, the recipient must submit the presentation for which they are being recognized, along with the author's consent, for online publication. The reward will be forfeited if the PPT and authorization are not submitted within the allotted period.

Award Announcements:
Official announcements of the recipients will occur after the completion of the ICO-2025

Meetings International has introduced a program to honor, celebrate, and promote excellence in its numerous conferences and events by presenting awards to attendees. We applaud and recognize accomplishment in this field that continually evolves and redefining what constitutes best practices. These awards recognize the highest level of professional performance for event professionals. Winning an award means that you have the unwavering support of our esteemed panel of top industry specialists, which is a reliable indicator of your impressive qualifications.

Outstanding Speaker in ICO-2025: This award honours academic and business speakers for their outstanding presenting abilities as well as the important contributions they make to their teams, patients, and professions in oncology through their clinical practice, leadership, or research efforts. The co-chair and session chair shall select the winner of this prize. Following the conclusion of the oral session, the recipients will receive congratulations. Researchers from all around the world are invited by our organization to participate as speakers at these esteemed gatherings.

Best Keynote Speaker in ICO-2025: The outstanding presentations made throughout the Oncology conference are honored with this award. Additionally, it honors the speaker's zeal and commitment to making everyone they come into contact with have a better experience. The impact of the presentation on the event participants will determine the recipient of the prize. The references gathered from the keynote speaker's citations will also be considered. One of the organizing panel members who is in attendance at the conference will deliver these awards to the recipients.

Best Organising Committee Member in ICO-2025: The purpose of this award is to honor the members of the conference's organizing committee for their ongoing assistance. The ICO-2025 operating committee will choose the winner of this prize. Based on a member of the organizing panel's assistance and collaboration from the start of the conference until its successful conclusion, the award will be granted.

Outstanding Masters/Ph.D./Postdoc Thesis work presentation in ICO-2025: The goal of this award is to honor the bright young minds of today. The judge of the Young Researchers Forum will decide the recipient of this award. The importance of the research and its applications in the field of oncology, as well as the presenter's talents, will determine the recipient of this award. This grant is open to those pursuing post-doctoral, master's, or doctoral degrees. Following the conclusion of all oral presentations made under the Young Researchers Forum category, the honorees will be given a formal reception.

Best Poster Award in ICO-2025:  The most outstanding poster presentation delivered during an event is honored with this prize. The poster session judge will choose the recipient of this award. A poster that has won an award will be assessed based on its scientific elements, communication standards, originality of approach, and presenting content and clarity. In addition, it will be based on the description's layout, analysis, and findings from cancer research. Following the conclusion of the poster session, the recipients will be presented with awards.

The award is bestowed upon our oncology conferences to recognize the extensive responsibilities and dedication of cancer researchers who pioneer the most rapid advancements and creative approaches in the fields of oncology editing and cancer research.

Criteria:

• All abstracts submitted will be automatically nominated for the Award.
• The judges for each award category will choose all of the winners.
• The concluding event will feature a formal announcement of the winners.
• A certificate of achievement will be given to the Poster Award winners.
• The concept and format, intellect, argumentation and approach, familiarity with previous work, engaging quality, message and key issues, parity of content graphics, and overall impression will all be taken into consideration when evaluating the awards.

Guidelines:

• Submissions must be written in English.
• The subject must be appropriate for the conference's scientific sessions.
• A maximum of two papers may be submitted by each participant.
• The provided abstract template must be followed when submitting the abstract online.
• Abstracts have to be written in Times New Roman with a 12-point font.
• Title, name, association, nation, speaker bio, current photo, image, and reference must all be included in the abstract.
• Every poster needs to measure roughly 1 x 1 M long. At a distance of 1-2 feet, the author's information, the title, and the contents should all be easily readable.

Reach important minds by advertising with Meetings International and get seen with the material that matters. Global leaders in organizing top-notch conferences and workshops in all important domains of research, technology, and medicine are Meetings International.

Doctors, engineers, young and aspiring researchers, entrepreneurs, famous scientists, professors, and Nobel laureates from a variety of medical and non-medical science fields visit the websites of Meetings International Conferences. We can target ad impressions based on conference topic or geography, and we can provide detailed outcomes reporting.

The 4^th International Conference on Oncology invites small and medium-sized enterprises to use its website as a digital platform for product and service advertising. This will undoubtedly aid in rapidly and effectively educating and drawing in new clients. Our extensive and varied selection of advertising alternatives offers clients the greatest personalized marketing experiences. The finest opportunity to market your business and showcase your goods or services is through the advertising platform we offer. This is the ideal location for you if you want to promote your goods and services internationally. Display advertising increases the awareness of your goods and services among industry experts. Using a banner ad placement, you can make your product come to life and instantly increase brand awareness. Create an interactive banner to help guide.

Our subscribers and conference goers may become your future, ardent clients. Here's your chance to advertise on the website that can put you in contact with top scientists and aquaculture professionals across the globe if you sell related products or services.

The advertising provider must supply the banner ads, and they must be in jpeg or jpg format. High resolution and no copyright violation are requirements for the banner. Please get in touch with our representative if you have any questions about advertising opportunities:

• Contact Person: Joseph Hilton
• Contact Email: oncology@theexpertsmeet.com
• WhatsApp: +447520604474